Get started
GlaxoSmithKline S.A.E.GlaxoSmithKline S.A.E.GlaxoSmithKline S.A.E.

GlaxoSmithKline S.A.E.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BIOC chart


Full chart

Key stats


Market capitalization
‪5.31 B‬ EGP
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
—
Revenue (FY)
—
Shares float
‪2.43 M‬
Beta (1Y)
0.65

About GlaxoSmithKline S.A.E.


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
gsk.com
Headquarters
Cairo
Founded
1981
ISIN
EGS38171C012
FIGI
BBG000C18255
GlaxoSmithKline (Egypt) engages in the pharmaceutical and healthcare business. Its business operations are carried out through the production, packaging, marketing, sale, and distribution of medicines and other pharmaceutical products. The company was founded on January 14, 1981 and is headquartered in Cairo, Egypt.

Check out other big names from the same industry as BIOC.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BIOC news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BIOC is 63.630 EGP — it has increased by 0.02% in the past 24 hours. Watch GlaxoSmithKline S.A.E. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange GlaxoSmithKline S.A.E. stocks are traded under the ticker BIOC.
BIOC stock has fallen by −6.29% compared to the previous week, the month change is a 20.06% rise, over the last year GlaxoSmithKline S.A.E. has showed a 91.20% increase.
BIOC reached its all-time high on Sep 8, 2025 with the price of 81.500 EGP, and its all-time low was 5.770 EGP and was reached on Mar 18, 2020. View more price dynamics on BIOC chart.
See other stocks reaching their highest and lowest prices.
BIOC stock is 5.24% volatile and has beta coefficient of 0.65. Track GlaxoSmithKline S.A.E. stock price on the chart and check out the list of the most volatile stocks — is GlaxoSmithKline S.A.E. there?
Today GlaxoSmithKline S.A.E. has the market capitalization of ‪5.31 B‬, it has decreased by −3.52% over the last week.
Yes, you can track GlaxoSmithKline S.A.E. financials in yearly and quarterly reports right on TradingView.
BIOC net income for the last quarter is ‪59.12 M‬ EGP, while the quarter before that showed ‪−8.99 M‬ EGP of net income which accounts for 757.63% change. Track more GlaxoSmithKline S.A.E. financial stats to get the full picture.
Yes, BIOC dividends are paid annually. The last dividend per share was 0.75 EGP. As of today, Dividend Yield (TTM)% is 1.18%. Tracking GlaxoSmithKline S.A.E. dividends might help you take more informed decisions.
Like other stocks, BIOC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GlaxoSmithKline S.A.E. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GlaxoSmithKline S.A.E. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GlaxoSmithKline S.A.E. stock shows the strong buy signal. See more of GlaxoSmithKline S.A.E. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.